The second act of a popular reprogramming factor could maximize the potential of iPSCs in research and regenerative medicine.

In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with potentially increased effectiveness and safety for the treatment for ...

Scientists have created a revolutionary method to disable mosquitoes' ability to transmit deadly diseases. This ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Just in time as warmer weather draws near, the final West Virginia Wesleyan College Faculty Lecture Series of the year will ...

To tackle data-retrieval-based hallucinations in non-diagnostic use cases, Mayo Clinic has applied CURE reverse RAG paired ...

LONDON, UK & CHICAGO, IL, USA I March 05, 2025 I Anova Enterprises, Inc. (Anova), a technology-enabled CRO dedicated to accelerating promising treatments, ...

The type of tick most commonly known to carry the bacterium that causes Lyme disease has been identified in eastern Montana, according to new National Institutes of Health (NIH) research. […] ...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce a Request for ...